Review Article

Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases

Table 1

Summary of the main genetic and clinical features of FMF, TRAPS, CAPS, and MKD.

DiseaseGene locusInheritanceProteinMain clinical features

FMFMEFV
16p13.3
ARPyrinFever, serositis, arthritis generally affecting large joints, erysipelas-like rash, and systemic AA amyloidosis in untreated patients

TRAPSTNFRSF1A
12p13
ADTumor necrosis factor receptor 1Fever, migrating erythematous skin rash, muscle pain due to monocytic fasciitis, periorbital edema, arthralgia or arthritis, serosal involvement, and systemic AA amyloidosis in untreated patients

FCASNLRP3
1q44
ADCryopyrinFever, cold-induced urticaria-like rash, conjunctivitis, and arthralgia
MWSFever, urticaria-like rash, conjunctivitis, arthralgia, neurosensorial deafness, and risk of amyloidosis
CINCAFever, urticaria-like rash, uveitis, papilledema, deforming arthritis mainly involving large joints, chronic aseptic meningopathy, neurosensorial deafness, and risk of amyloidosis

HIDSMVK
12q24
ARMevalonate kinaseFever, polymorphous rash, arthralgia, abdominal pain, diarrhea, lymph node enlargement, splenomegaly, and aphthosis
MEVAPsychomotor retardation, growth delay, progressive cerebellar ataxia, dysmorphisms, and vision deficits in addition to HIDS features

List of abbreviations: AD—autosomal dominant; AR—autosomal recessive; CINCA—chronic infantile neurologic cutaneous and articular syndrome; FCAS—familial cold autoinflammatory syndrome; FMF—familial Mediterranean fever; HIDS—hyperimmunoglobulinemia D syndrome; MEFV—Mediterranean fever; MEVA—mevalonic aciduria; MKD—mevalonate kinase deficiency; MVK—mevalonate kinase; MWS—Muckle-Wells syndrome; NLRP3—NACHT, LRR, and PYD domain-containing protein 3; TNFRSF1A—tumor necrosis factor receptor super family 1A; TRAPS—tumor necrosis factor-associated periodic syndrome.